KalVista Pharmaceuticals, Inc.
NASDAQ · us_market
No AI insight generated yet for this ticker.
KalVista Pharmaceuticals, Inc., a biopharmaceutical company, develops oral therapies for individuals for rare diseases with unmet needs. Its lead product candidate is EKTERLY, a fast-acting potent inhibitor of plasma kallikrein for the treatment of acute attacks of hereditary angioedema (HAE). The company is also developing is developing an orally disintegrating tablet formulation; KONFIDENT-KID for pediatric use with HAE; KONFIDENT; and KONFIDENT-S to evaluate sebetralstat and ODT formulation in adolescent and adult patients. KalVista Pharmaceuticals, Inc. is headquartered in Framingham, Massachusetts.
| Fund | Style | Shares | Value | % of Port | Change vs. last quarter | Period |
|---|---|---|---|---|---|---|
| Citadel | multi-strat | 2.14M | $43.02M | 0.06% | Trimmed-6.4% | 2026-03-31 |
| StateStreet | passive | 1.96M | $39.37M | 0.00% | Added+2.3% | 2026-03-31 |
| FidelityFMR | fundamental | 187.8K | $3.78M | 0.00% | Added+68.0% | 2026-03-31 |
| TwoSigma | quant | 153.5K | $3.09M | 0.00% | New | 2026-03-31 |
| Wellington | fundamental | 107.3K | $2.16M | 0.00% | Trimmed-12.4% | 2026-03-31 |
| TRowePrice | fundamental | 29.4K | $592 | 0.00% | Added+27.0% | 2026-03-31 |
| Report Date | EPS Estimate | EPS Actual | Surprise |
|---|---|---|---|
| 2026-08-13upcoming | -0.26 | — | — |
| 2026-05-14 | -0.38 | -0.43 | -14.29% |
| 2025-12-11 | -0.91 | — | — |
| 2025-07-10 | -0.81 | -0.99 | -21.89% |
| 2025-03-12 | -0.87 | -0.92 | -6.02% |
| 2024-12-04 | -0.91 | -0.91 | -0.22% |
| 2024-09-05 | -0.94 | -0.87 | +7.94% |
| 2024-07-11 | -0.72 | -1.07 | -48.27% |
| 2024-03-11 | -0.80 | -0.84 | -5.00% |
| 2023-12-07 | -0.78 | -0.80 | -2.13% |
| 2023-09-07 | -0.84 | -0.74 | +11.90% |
| 2023-07-06 | -0.87 | -0.77 | +11.29% |
| 2023-03-09 | -1.00 | -0.75 | +25.00% |
| 2022-12-08 | -1.05 | -0.90 | +14.29% |
| 2022-09-08 | -0.97 | -0.94 | +3.09% |
| 2022-07-07 | -1.09 | -0.98 | +9.82% |
| 30d | 90d | YTD | 1y | |
|---|---|---|---|---|
| KALV | +0.83% | +72.13% | +66.38% | +127.71% |
| XLV | +2.97% | -4.64% | -3.44% | +12.69% |
| Alpha (stock − sector) | -2.14% | +76.77% | +69.82% | +115.02% |